Latest stories on KURA
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma - Slideshow
Seeking Alpha55 · neutralproduct/pr
Kura Oncology, Inc. (KURA) files 8-K
SEC 8-K50 · neutralgeneral
Kura Oncology, Inc. (KURA) Discusses Updated FIT 001 Trial Results for Darlifarnib and Cabozantinib in Renal Cell Carcinoma Transcript
Seeking Alpha59 · neutralproduct/pr
Kura Oncology: A Menin Inhibitor Launch With More Than One Way To Win
Seeking Alpha67 · bullishproduct/pr
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KURA Stock News
StockTitan50 · neutralgeneral
Kura Sushi to Accelerate US Growth to Fend Off Rivals’ Expansion
Bloomberg63 · neutralproduct/pr
Kura Oncology, Inc. (KURA) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow
Seeking Alpha50 · neutralgeneral
Kura Oncology, Inc. (KURA) Discusses Clinical Data and Updated Development Strategy for Darlifarnib - Slideshow
Seeking Alpha55 · neutralproduct/pr
Kura Oncology Advances Targeted Combo in Tough Head and Neck Cancer
TipRanks63 · neutralproduct/pr
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | KURA Stock News
StockTitan50 · neutralgeneral
Kura Oncology, Inc. (KURA) Discusses Clinical Data and Updated Development Strategy for Darlifarnib Transcript
Seeking Alpha56 · neutralproduct/pr
Kura Oncology Earnings Call Signals Early Launch Strength
TipRanks56 · neutralearnings
Kura Oncology, Inc. Q1 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
Kura Oncology Q1 Earnings Call Highlights
Yahoo Finance56 · neutralearnings